Ikarian Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-40,000
| Closed | -$5.51M | – | 120 |
|
|
2024
Q2 | $5.51M | Buy |
+40,000
| New | +$5.51M | 0.96% | 17 |
|
|
2022
Q3 | – | Sell |
-38,600
| Closed | -$3.76M | – | 103 |
|
|
2022
Q2 | $3.76M | Buy |
+38,600
| New | +$3.76M | 0.69% | 22 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 169 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 219 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 172 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 115 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 103 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 72 |
|